Skip to main content
OpenTrials

Clinical trial condition

Triple Negative Breast Cancer

Explore clinical trials studying Triple Negative Breast Cancer. Study availability and eligibility vary by location and protocol.

294 public trials 113 recruiting studies
Refine in advanced search Browse all conditions

Triple Negative Breast Cancer trial results

Recruiting

A Study of Sacituzumab Govitecan Given at an Alternative Dose and Schedule in Participants With Advanced Triple-Negative Breast Cancer

NCT06926920

Conditions
Breast Diseases, Breast Neoplasms, Neoplasms, +5 more
Locations
  • Los Angeles Cancer Network (LACN) - Good Sam Los Angeles, California, United States
  • Winship Cancer Institute - Emory University Atlanta, Georgia, United States
  • The University of Kansas Hospital Westwood, Kansas, United States
  • Siteman Cancer Center St Louis, Missouri, United States
View all 16 locations
View Trial Details
Recruiting

Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors

NCT05983432

Conditions
Adnexal Diseases, Breast Cancer, Breast Diseases, +62 more
Locations
  • Beverly Hills Cancer Center Beverly Hills, California, United States
  • City of Hope Cancer Center Duarte, California, United States
  • Chao Family Comprehensive Cancer Care and Ambulatory Care Irvine, California, United States
  • Chao Family Comprehensive Cancer Center and Ambulatory Care Irvine, California, United States
View all 39 locations
View Trial Details
Recruiting

Study of Antivascular Therapy Combined With Chemotherapy Versus Chemotherapy in Adjuvant Therapy of TNBC-BLIS Patients (BCTOP-T-A03)

NCT05909332

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +6 more
Locations
  • Beijing Cancer Hospital Beijing, Beijing Municipality, China
  • Chongqing Cancer Hospital Chongqing, Chongqing Municipality, China
  • Fujian Medical University Union Hospital Fuzhou, Fujian, China
  • Guangdong Academy of Medical Sciences Guangdong Provincial People's Hospital Guangzhou, Guangdong, China
View all 15 locations
View Trial Details
Recruiting

Neoadjuvant INBRX-106 in Combination With Pembrolizumab for Stage II/III TNBC Patients

NCT06353997

Conditions
Breast Diseases, Breast Neoplasms, Neoplasms, +5 more
Locations
  • Ellison Institute of Technology (EITM) Los Angeles, California, United States
  • Providence Portland Cancer Institute - Franz Clinic Portland, Oregon, United States
  • Providence St. Vincent Medical Center Portland, Oregon, United States
  • Swedish Cancer Institute Seattle, Washington, United States
View Trial Details
Recruiting

A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas

NCT06999187

Conditions
Adnexal Diseases, Breast Diseases, Breast Neoplasms, +55 more
Locations
  • Dren Investigational Site Denver, Colorado, United States
  • Dren Investigational Site Orlando, Florida, United States
  • Dren Investigational Site Sarasota, Florida, United States
  • Dren Investigational Site Huntersville, North Carolina, United States
View Trial Details
Recruiting

A Study to Investigate APL-5125 in Adults With Advanced Solid Tumors

NCT06399757

Conditions
Adenocarcinoma, Adenocarcinoma, Mucinous, Adnexal Diseases, +46 more
Locations
  • City of Hope Duarte, California, United States
  • City of Hope Orange County Lennar Foundation Cancer Center Irvine, California, United States
  • Florida Cancer Specialists & Research Institute Sarasota, Florida, United States
  • University of Michigan Ann Arbor, Michigan, United States
View Trial Details
Recruiting

A Dose Escalation and Dose Expansion Study of Intratumoral ONM-501 Alone and in Combination With Cemiplimab in Patients With Advanced Solid Tumors and Lymphomas.

NCT06022029

Conditions
Bites and Stings, Bladder Cancer, Breast Diseases, +72 more
Locations
  • California Research Institute Los Angeles, California, United States
  • BRCR Global Tamarac, Florida, United States
  • Gabrail Cancer Center Research Canton, Ohio, United States
  • Ohio State University Columbus, Ohio, United States
View all 16 locations
View Trial Details

Related conditions